A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia
Phase 2 Completed
171 enrolled
05-001: Treatment of Acute Lymphoblastic Leukemia in Children
Phase 3 Completed
800 enrolled 22 charts
Dasatinib Combined With Chemotherapy in Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia
Phase 2 Completed
30 enrolled
Clofarabine or High-Dose Cytarabine and Pegaspargase in Children with ALL
Phase 2/3 Completed
745 enrolled
Rituximab, Chemotherapy, and Filgrastim in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia
Phase 2 Completed
105 enrolled 8 charts
Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia
Phase 3 Completed
838 enrolled
Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia
Phase 3 Completed
1,076 enrolled
Therapy for Pediatric Relapsed or Refractory Precursor B-Cell Acute Lymphoblastic Leukemia and Lymphoma
Phase 2 Completed
80 enrolled 13 charts
Hyper-CVAD With Liposomal Vincristine in Acute Lymphoblastic Leukemia
Phase 2 Completed
31 enrolled 9 charts
Total Therapy Study XVI for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia
Phase 3 Completed
600 enrolled 16 charts
International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia
Phase 3 Completed
6,136 enrolled
LAL1308
Phase NA Completed
76 enrolled
Modified Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) Program for Acute Lymphoblastic Leukemia
Phase 2 Completed
220 enrolled 6 charts
Therapy for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia
Phase 3 Completed
501 enrolled 12 charts
Two Combination Chemotherapy Regimens in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia
Phase 3 Completed
2,231 enrolled
Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
Phase 2 Completed
35 enrolled
High-Intensity, Brief-Duration Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphocytic Leukemia
Phase 2 Completed
25 enrolled
E7070, Idarubicin and Cytarabine in Relapsed AML and High-Risk Myelodysplastic Syndromes
Phase 2 Completed
43 enrolled 11 charts
Rituximab and Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) for Burkitt's and Burkitt's -Like Leukemia/Lymphoma
Phase 2 Completed
56 enrolled 6 charts
Phase 1 Clinical Trial of NPI-0052 in Patients With Advanced Malignancies
Phase 1 Completed
86 enrolled
Therapy for Pediatric Relapsed or Refractory Acute Lymphoblastic Leukemia
Phase 2 Completed
47 enrolled 10 charts
A Pilot Study of Lenalidomide, Melphalan and Dexamethasone in AL Amyloidosis
Phase NA Completed
25 enrolled 12 charts
Combination Chemotherapy and Radiation Therapy in Treating Patients With Acute Lymphoblastic Leukemia That Has Relapsed in the CNS or Testes
Phase NA Completed
168 enrolled 10 charts
Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia
Phase 3 Completed
1,970 enrolled
Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia
Phase 2 Completed
134 enrolled
Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant
Phase NA Completed
40 enrolled 9 charts
Comparison of Different Combination Chemotherapy Regimens in Treating Children With Acute Lymphoblastic Leukemia
Phase 3 Completed
3,054 enrolled
Biomarkers to Classify Young Patients With Acute Lymphoblastic Leukemia (ALL) and Remission Induction Therapy in Young Patients With B-Precursor ALL
Phase NA Completed
3,762 enrolled
Blood and Marrow Transplant Clinical Research Network
Phase NA Completed
Study of Hyper-CVAD Plus Imatinib Mesylate for Philadelphia-Positive Acute Lymphocytic Leukemia
Phase 2 Completed
54 enrolled 7 charts
Methotrexate, Vincristine, Pegylated L-Asparaginase and Dexamethasone (MOAD) in Acute Lymphoblastic Leukemia (ALL) Salvage
Phase 2 Completed
37 enrolled 6 charts
Phenylbutyrate, Dexamethasone, and Sargramostim in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia
Phase 2 Completed
SWOG-9400 Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Previously Untreated Acute Lymphocytic Leukemia
Phase 2 Completed
50 enrolled
AIEOP LLA 2000
Phase 3 Completed
2,039 enrolled
Combination Chemotherapy in Treating Children With Very High Risk Acute Lymphocytic Leukemia
Phase 2 Completed
36 enrolled
Combination Chemotherapy in Treating Children With Stage III or Stage IV Non-Hodgkin's Lymphoma or Acute Lymphoblastic Leukemia
Phase 1 Completed
20 enrolled
Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphocytic Leukemia
Phase 2 Completed
59 enrolled
Combination Chemotherapy, Bone Marrow Transplantation, and Radiation Therapy in Treating Infants With Acute Lymphoblastic Leukemia
Phase 2 Completed
CINJALL: Treatment for Children With Acute Lymphocytic Leukemia
Phase 2 Completed
60 enrolled 8 charts
Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia
Phase 3 Completed
276 enrolled
Combination Chemotherapy With or Without Donor Bone Marrow Transplantation in Treating Infants With Previously Untreated Acute Lymphoblastic Leukemia
Phase 2 Completed
6 enrolled
Combination Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Leukemia
Phase 1 Completed
23 enrolled
Combination Chemotherapy in Treating Children With Acute Lymphocytic Leukemia
Phase 3 Completed
2,078 enrolled
Combination Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia
Phase 3 Completed
120 enrolled
Combination Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
Phase 3 Completed
470 enrolled
Combination Chemotherapy in Treating Patients With Acute B-Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma
Phase 2 Completed
Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic Leukemia
Phase 3 Completed
392 enrolled
Combination Chemotherapy Based on Risk of Relapse in Treating Young Patients With Acute Lymphoblastic Leukemia
Phase 3 Completed
4,559 enrolled
Radiation Therapy and Chemotherapy in Treating Children With CNS Relapse From Acute Lymphoblastic Leukemia
Phase 2 Completed
156 enrolled
High-Dose Chemotherapy Followed by Total-Body Irradiation and Peripheral Stem Cell Transplantation in Treating Patients With Chronic Lymphocytic Leukemia
Phase 1 Completed
15 enrolled